In this short State of the Science spotlight, Dr. Keren Sturtz , Executive Senior Director at Pfizer Oncology Early Clinical Development, shares why breakthroughs in pediatric brain cancer depend on one thing above all: everyone working together. Dr. Sturtz explains why rare pediatric brain tumors require creative thinkers, strong research infrastructure, and the combined efforts of academic centers, biotech innovators, big pharma, government funding—and philanthropy. She highlights how each...